UK Life Sciences Company Directory

Non-profit CRO specialising in clinical trial data and biostatistics

Frontier Science (Scotland) is a not-for-profit contract research organisation providing data management, biostatistics, and quality assurance services for clinical trials. The company works with both academic and commercial sponsors across all phases, with particular strength in large-scale international Phase II and…

Proteomics and AI liquid biopsy for early lung cancer detection

Oxford Cancer Analytics is a biotechnology company developing blood-based diagnostic tests for early cancer detection using high-throughput circulating proteome analysis and machine learning. Its platform identifies protein biomarker signatures from blood samples to support clinical decision-making in lung disease,…

Reprogrammed stem cell therapies for vascular disease and chronic wounds

ReproGo is a Belfast-based regenerative medicine company developing Advanced Therapy Medicinal Products through direct cell reprogramming of adult cells into vascular lineages. The company's manufacturing approach produces stem cell-derived vascular cells and organoids through a xeno-free, low-dose process designed…

Microbial gas fermentation for carbon recycling and renewable fuels

LanzaTech is an industrial biotechnology company developing microbial gas-fermentation technology to convert waste carbon into ethanol and other chemicals. Its platform uses specialised acetogenic bacteria to process industrial off-gases and gasified waste, with applications in fuels, materials and chemical…

Bispecific antibody-drug conjugates for hard-to-treat solid tumours

Valink Therapeutics is a biotechnology company developing next-generation bispecific antibody-drug conjugates and multispecific antibody therapeutics for oncology. Its proprietary discovery platform enables modular assembly of complex antibody formats combining multispecificity, multivalency, and drug conjugation,…

AI-driven isoform sequencing platform for movement disorder and ageing research

Entelo Bio is an Oxford-based biotechnology company developing a proprietary single-cell isoform sequencing and AI platform to decode disease biology in conditions affecting human movement and ageing. Built on research from the University of Oxford's Botnar Institute for Musculoskeletal Sciences, the platform combines…

Synthetic polymer affinity ligands for viral vector bioprocessing

Tozaro is a biotechnology company developing synthetic polymer-based affinity ligands to improve the downstream processing of viral vectors used in cell and gene therapy. Using molecular modelling and machine learning, Tozaro rationally designs polymer-based binders from a chemical space of over 500 monomers, offering…

Non-viral gene therapy platform enabling durable nuclear DNA delivery

Gramics Bio develops a gene therapy platform solving a key limitation of lipid nanoparticle delivery: enabling therapeutic DNA to reach the cell nucleus for durable expression without viral vectors. By programming specificity into synthetic DNA sequences rather than new delivery chemistries, the technology combines…

Gene editing platform for disease-resistant, climate-resilient tropical crops

Tropic Biosciences is an agricultural biotechnology company developing gene-edited varieties of tropical crops, including banana, coffee, and rice, with a focus on disease resistance, climate resilience, and yield improvement. Its proprietary platform combines gene editing with RNA interference to redirect a plant's…

Bioanalytical CRO for drug quantification across development stages

Alderley Analytical is a contract research organisation providing bioanalytical testing services across the drug development continuum, from discovery through preclinical safety studies to clinical trials. The company specialises in mass spectrometry and ligand binding assays for the quantification of small molecules,…

Evidence-based biomedical AI for precision health applications

Pharmatics is a biomedical software company developing evidence-informed artificial intelligence models for digital health and precision medicine. Its MedAI platform combines clinical data with findings from biomedical literature to generate predictive models, risk scores and decision-support tools. Services include…

Lab-grown human muscle platform for preclinical drug testing and safety assessment

Myomaker Bio is a UK-based CRO specialising in pre-clinical muscle biology. The company has developed a platform of lab-grown human skeletal muscle tissues and organs that replicate the structure and function of native muscle, enabling researchers to study drug response, toxicity, injury and regeneration under…

Full-service CRO specialising in academic and spin-out clinical trials

PHARMExcel is a UK contract research organisation providing full-service clinical trial support across Phases I to IV for academic institutions, NHS bodies, spin-outs and commercial sponsors. Services span protocol design, regulatory affairs, study management, monitoring and grant funding support. The company holds…

Transformative medicines for cystic fibrosis and serious genetic diseases

Vertex Pharmaceuticals is a global biopharmaceutical company with its European R&D headquarters at Milton Park, Oxfordshire, and its international commercial headquarters in London. The Oxford site conducts full-spectrum drug discovery encompassing human genetics, structural biology, and medicinal chemistry, and has…

Year-long subcutaneous drug-releasing implants for chronic disease management

imphatec is a drug delivery company developing subcutaneous implants that release medicines steadily for up to a year, with the aim of replacing daily tablets for people managing chronic and long-term conditions. Its implants are formulated to deliver a customised daily dose of a drug from a polymer matrix placed…

Automated chiral chemistry platform for small molecule drug discovery

LCC Technologies is a drug discovery company providing biopharma partners with access to its platform, which combines a proprietary billion-scale virtual chiral library with AI-driven design and automated high-throughput synthesis. The platform delivers stereodefined, sp3-rich building blocks and drug-like compounds…

Carbohydrate binding molecules targeting the tumour glycome in cancer

Omideon is a Scottish preclinical biotechnology company applying multivalent carbohydrate binding molecule (mCBM) technology to oncology. Spun out from Pneumagen Limited by demerger in 2020, the company uses genetic engineering to develop mCBMs with high affinity for tumour-associated terminal glycans. Its lead…

Rapid diagnostic test kits for clinical, pharmacy and consumer markets

CIGA Healthcare is an ISO 13485-certified manufacturer of rapid lateral flow diagnostic tests and immunoassay products, supplying pharmacy outlets, health services and retailers across more than 70 countries. Its brand covers point-of-care and over-the-counter tests for pregnancy, infectious disease, cardiac…

Alternative protein research, education and academic collaboration network

Cambridge University Alt Protein Project is a student-led ecosystem organisation connecting researchers, students and entrepreneurs working on alternative proteins. It supports education and collaboration across cultivated meat, plant-based foods and fermentation through workshops, academic mapping and scientific…

AI-powered biomedical evidence analysis and drug development research

rodent2human is a biomedical software company developing AI tools to support drug discovery and translational research. Its evidence-analysis platform combines scientific literature, biological databases and computational approaches to investigate therapeutic targets, mechanisms, safety signals and clinical relevance.…